Labinaz, M., Madan, M., McGuire, D. K., Batchelor, W., Saucedo, J., Pacchiana, C., … Tcheng, J. E. (2000). Effect of eptifibatide, a glycoprotein IIb/IIIa antagonist, among diabetic patients following coronary stenting: Results from ESPRIT. CIRCULATION, 102(18), 665-+.

Labinaz, M., M. Madan, D. K. McGuire, W. Batchelor, J. Saucedo, C. Pacchiana, M. M. Kitt, et al. “Effect of eptifibatide, a glycoprotein IIb/IIIa antagonist, among diabetic patients following coronary stenting: Results from ESPRIT.” CIRCULATION 102, no. 18 (October 31, 2000): 665-+.

Labinaz M, Madan M, McGuire DK, Batchelor W, Saucedo J, Pacchiana C, et al. Effect of eptifibatide, a glycoprotein IIb/IIIa antagonist, among diabetic patients following coronary stenting: Results from ESPRIT. CIRCULATION. 2000 Oct 31;102(18):665-+.

Labinaz, M., et al. “Effect of eptifibatide, a glycoprotein IIb/IIIa antagonist, among diabetic patients following coronary stenting: Results from ESPRIT.” CIRCULATION, vol. 102, no. 18, LIPPINCOTT WILLIAMS & WILKINS, Oct. 2000, pp. 665-+.

Labinaz M, Madan M, McGuire DK, Batchelor W, Saucedo J, Pacchiana C, Kitt MM, O’Shea JC, Talley DJ, Liu H, Timmis S, Tcheng JE. Effect of eptifibatide, a glycoprotein IIb/IIIa antagonist, among diabetic patients following coronary stenting: Results from ESPRIT. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2000 Oct 31;102(18):665-+.